121 filings
Page 4 of 7
8-K
68r9kgdhugr
16 May 22
Vivos Therapeutics Reports First Quarter 2022
4:10pm
8-K
cqwfe0p6me0j 20bsct
31 Mar 22
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
5:13pm
8-K
kac 5wbds8ako4
1 Mar 22
Departure of Directors or Certain Officers
5:15pm
EFFECT
vokhxy u6qoa35
15 Feb 22
Notice of effectiveness
12:15am
CORRESP
1tgnn9n741n izpu
14 Feb 22
Correspondence with SEC
12:00am
UPLOAD
xh7kb07ef26ev
14 Feb 22
Letter from SEC
12:00am
S-3
xn26c5cfw65v0ow
7 Feb 22
Shelf registration
9:33am
8-K
3et888jk
15 Nov 21
Vivos Therapeutics Reports Third Quarter 2021 Financial Results
4:15pm
8-K
64ybv kue
27 Sep 21
Entry into a Material Definitive Agreement
9:00am
8-K
3heerk5sf1r
12 Aug 21
Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update
4:15pm
8-K
3b1g3r
29 Jul 21
Submission of Matters to a Vote of Security Holders
4:15pm
DEF 14A
qzy6d3ttwlduastjl
29 Jun 21
Definitive proxy
4:38pm
8-K
i97a9jj
17 Jun 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:01pm
S-8
udw9uees3sbo
11 Jun 21
Registration of securities for employees
5:16pm
EFFECT
bbf2ems6ft obn
20 May 21
Notice of effectiveness
12:15am
424B4
kj3ewj
19 May 21
Prospectus supplement with pricing info
5:30pm